The Subject Expert Committee of Central Drug Standard Control Organization on Saturday recommended Bharat Biotech\'s \'Covaxin\' for emergency use in India. The final decision on its approval will, however, be taken by the Drug Controller General of India (DCGI). DCGI will conduct a press conference today. Notably, the panel recommended emergency

source https://news.abplive.com/india/will-we-get-nod-for-vaccines-emergency-use-dcgi-press-conference-at-11-am-1427978